ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Rall, FDA Chief On AACR Panel

April 27, 1979

Bethesda System Revised For Reporting Pap Test Results

April 26, 2002

MIT’s Robert Weinberg Says He Doesn’t Advise Young People To Enter Career In Cancer Research.

April 7, 2006

DCPC Board Ponders Screening Recommendations: Should NCI Have Policies? If So, What Will They Be?

September 26, 1986

Congress Asked To Equalize Cuts, Add $20 million For Centers

April 25, 1980

Group Chairmen Cool To New Groups, Told Their Remarks Are Inappropriate

July 21, 1978